IPG Photonics (IPGP) Q4 2025 earnings summary

Executive summary

• Fourth quarter revenue rose 17% year-over-year to $274.5 million, driven by strong growth in materials processing, medical, and advanced applications, with stable industrial demand and new business in battery production.

• Net income for the quarter was $13.3 million, up 71% year-over-year; adjusted EBITDA reached $41.2 million, an 11% increase year-over-year, and adjusted EPS was $0.46, up 53%.

• Strategic focus on high-value applications and innovation led to record medical sales, successful integration of cleanLASER, and the launch of new products.

• Book-to-bill ratio above one in Q4 signals improving market conditions and strengthening demand.

• Full-year revenue grew 3% to $1,003.8 million, marking the first annual growth since 2021.

Financial highlights

• Q4 revenue reached $274.5 million, up 17% year-over-year and 9% sequentially; foreign currency contributed $6 million.

• GAAP gross margin was 36.1%, down from 38.6% a year ago, impacted by tariffs and higher product costs; adjusted gross margin was 37.6%.

• GAAP operating income was $3 million; adjusted EBITDA $41.2 million; GAAP net income $13.3 million ($0.31 per share); adjusted net income $20 million ($0.46 per share).

• Operating expenses increased 21% year-over-year, mainly due to growth investments and acquisition-related costs.

• Ended the quarter with $839 million in cash and no debt; full-year free cash flow was $75 million.

Outlook and guidance

• Q1 2026 revenue expected between $235 million and $265 million, with seasonality impacting results.

• Adjusted gross margin guidance of 37%-39%, with tariffs expected to impact margins by 150 basis points.

• Adjusted EPS forecasted at $0.10-$0.40; adjusted EBITDA $25-$40 million.

• CapEx for 2026 projected at $90-$100 million, reflecting delayed investment in Germany.

• Operating expenses for Q1 2026 projected at $90–$92 million.